Circulating DNA as a Strong Multimarker Prognostic Tool for Metastatic Colorectal Cancer Patient Management Care.

Safia El Messaoudi1, Florent Mouliere1, Stanislas Du Manoir1

  • 1IRCM, Institut de Recherche en Cancérologie de Montpellier, Montpellier, France. INSERM, U1194, Montpellier, France. Université de Montpellier, Montpellier, France. Institut régional du Cancer de Montpellier, Montpellier, France.

Summary

Multiparametric analysis of circulating cell-free DNA (ccfDNA) in metastatic colorectal cancer (mCRC) patients reveals its prognostic value. High ccfDNA levels and fragmentation are linked to shorter overall survival, establishing ccfDNA as an independent prognostic factor.

Related Concept Videos